Description |
asialoglycoprotein receptor 1 |
dihydrofolate reductase |
Image |
|
|
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
- NADH
- Pyrimethamine
- Methotrexate
- Pemetrexed
- Gentamicin
- Proguanil
- Trimetrexate
- 2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine
- 2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline
- 6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine
- N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine
- 2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine
- Sri-9662
- 2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium
- Sri-9439
- Nicotinamide adenine dinucleotide phosphate
- Piritrexim
- Biopterin
- 2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine
- Iclaprim
- Pralatrexate
- 5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine
- 5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine
- 5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine
- 5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine
- 5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine
- [N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE
- (4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol
- (2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine
|
Diseases |
|
|
GWAS |
- Apolipoprotein B levels ( 32203549)
- LDL cholesterol levels ( 32203549)
- Liver enzyme levels (alkaline phosphatase) ( 22001757)
- Low density lipoprotein cholesterol levels ( 32154731)
- Medication use (HMG CoA reductase inhibitors) ( 31015401)
- Serum alkaline phosphatase levels ( 31666285 29403010)
|
- Brain morphology (MOSTest) ( 32665545)
- Cortical surface area (MOSTest) ( 32665545)
- Glomerular filtration rate (creatinine) ( 26831199)
- Huntington's disease progression ( 28642124)
- Idiopathic downbeat nystagmus ( 32157568)
- Shingles ( 25297839)
- Subcortical volume (MOSTest) ( 32665545)
|
Interacting Genes |
43 interacting genes:
AHNAK2
AMIGO1
APH1A
APP
ASGR2
ATP1B4
BLCAP
CERS2
CLDN7
CLEC4G
CPLX4
CREB3L1
CYB5R3
DHFR
ERGIC3
FAM209A
FCGR1A
FNDC9
GPX8
HIBADH
HIVEP1
HSP90AA1
HSP90B1
IGFBP5
KIR2DL3
LAMTOR5
LEUTX
LMNA
MCEMP1
NEMP1
NLK
PDZK1IP1
RBBP6
RNF19B
SAR1A
SLC10A1
SLC35C2
SPAG4
SUSD3
TG
TMX2
VKORC1
VSIR
|
10 interacting genes:
AMFR
ASGR1
CDC42
FKBP1A
GKAP1
HSPD1
MDM2
THBS1
TOMM20
TP53
|
Entrez ID |
432 |
1719 |
HPRD ID |
00151 |
00519 |
Ensembl ID |
ENSG00000141505
|
ENSG00000228716
|
Uniprot IDs |
P07306
Q6FGQ5
|
B0YJ76
B4DM58
P00374
|
PDB IDs |
1DV8
5JPV
5JQ1
|
1BOZ
1DHF
1DLR
1DLS
1DRF
1HFP
1HFQ
1HFR
1KMS
1KMV
1MVS
1MVT
1OHJ
1OHK
1PD8
1PD9
1PDB
1S3U
1S3V
1S3W
1U71
1U72
1YHO
2C2S
2C2T
2DHF
2W3A
2W3B
2W3M
3EIG
3F8Y
3F8Z
3F91
3FS6
3GHC
3GHV
3GHW
3GI2
3GYF
3L3R
3N0H
3NTZ
3NU0
3NXO
3NXR
3NXT
3NXV
3NXX
3NXY
3NZD
3OAF
3S3V
3S7A
4DDR
4G95
4KAK
4KBN
4KD7
4KEB
4KFJ
4M6J
4M6K
4M6L
4QHV
4QJC
5HPB
5HQY
5HQZ
5HSR
5HSU
5HT4
5HT5
5HUI
5HVB
5HVE
6A7C
6A7E
6DAV
6DE4
6VCJ
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|